Toddlers' Responses to Strangers
Launched by UNIVERSITY OF CALIFORNIA SANTA CRUZ · Aug 9, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "The Malleability of Social Group Understanding in Infancy and Early Childhood," is exploring how children develop their social preferences and understanding of different races. The researchers want to find out if interacting with children from different races changes how kids think about race and social relationships compared to when they interact only with children of the same race.
The study is looking for children aged 5 to 7 years who are typically developing and speak English. If your child fits this description, they may be eligible to participate. During the trial, children will engage in activities that allow them to interact with peers from various racial backgrounds. This could help researchers understand how these interactions influence children's social behavior and perceptions about race. If you’re interested in this study, it’s a great opportunity for kids to learn and grow in a diverse environment!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • typically developing
- • age 13-24 months
- Exclusion Criteria:
- • - any known developmental delays
About University Of California Santa Cruz
The University of California, Santa Cruz (UCSC) is a leading research institution dedicated to advancing scientific knowledge and improving public health through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, UCSC leverages its diverse expertise in fields such as biology, psychology, and health sciences to conduct cutting-edge research. The university's clinical trial initiatives focus on addressing pressing health challenges, fostering the translation of research findings into effective interventions, and enhancing patient care. Committed to ethical standards and community engagement, UCSC strives to contribute meaningful advancements in medical science and to promote the well-being of the populations it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Santa Cruz, California, United States
Patients applied
Trial Officials
Hyesung Hwang, PhD
Principal Investigator
University of California Santa Cruz
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported